Medical News

RSS

Communication breakdown exists between people with chronic pain, health care providers: Survey

Conversations with health care providers can be challenging at times for all patients, but a new survey commissioned by HealthyWomen and conducted by Synovate Healthcare in July of 2010 reveals a concerning communications breakdown between people with chronic pain and their health care providers. More than one-third of chronic pain sufferers (36%) have simply learned to live with their often debilitating pain and may be reluctant to speak with a health care provider about their condition, according to a survey of women and men with chronic pain released today.

22 Sep 2010

Results of custirsen Phase 2 trial for advanced prostate cancer published in Journal of Clinical Oncology

OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.

22 Sep 2010

MHPA statement highlights common ground between Medicaid health plans, PCMH model

Today, Medicaid Health Plans of America released a policy statement and white paper highlighting the common ground between Medicaid health plans and the patient-centered medical home model. According to MHPA, the capabilities of Medicaid plans are closely aligned with the principles of PCMHs and therefore plans should be included in states' PCMH implementation strategies. MHPA's Policy Statement notes that collaboration between states, medical home providers and health plans is essential for coordinating complex inpatient and outpatient needs of Medicaid beneficiaries.

22 Sep 2010

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.

22 Sep 2010

Forensic DNA World Map Project launched

United States-based firm Gordon Thomas Honeywell Governmental Affairs (GTH-GA) announced the launch of the Forensic DNA World Map Project (WMP), a new component to GTH-GA's popular DNAResource.com, which monitors developments in forensic DNA policy. GTH-GA's president, Tim Schellberg, made the announcement in Lyon, France during INTERPOL's 6th International DNA User's Conference.

22 Sep 2010

George Higginson Professor to receive 2010 Warren Alpert Foundation Prize

Howard Green, a founding father of regenerative medicine and the George Higginson Professor of Cell Biology at Harvard Medical School, will receive the 2010 Warren Alpert Foundation Prize for developing methodologies leading directly to permanent skin restoration therapy which is saving the lives of thousands of burn patients around the world.

22 Sep 2010

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

$Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures$

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

Spanish researchers have confirmed there is a genetic risk factor for osteoporosis and bone fractures. Although more studies are still needed, these findings will make it possible to take preventive measures.

22 Sep 2010

Study finds no benefit from self-management counseling in patients with heart failure

Patients with mild to moderate heart failure who received educational materials and self-management counseling in an attempt to improve adherence to medical advice did not have a reduced rate of death or hospitalization compared to patients who received educational materials alone, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

Feeding Your Kids challenges families to take 42-day program to combat childhood obesity

Feeding Your Kids is proud to announce its participation in the Clinton Global Initiative Annual Meeting taking place from September 20-23 in New York City, and bringing together Initiative members from around the world to address a variety of global problems through tangible Commitments to Action. In honor of the annual meeting and Childhood Obesity Awareness Month, Feeding Your Kids is challenging families nationwide to take its 42-day program and change the way they feed their families.

22 Sep 2010

Newborn Coalition praises SACHDNC's Critical Congenital Heart Disease universal screening recommendation

In a historic vote on September 17, 2010, the Secretary's Advisory Committee for Heritable Disorders in Newborns and Children (SACHDNC) unanimously agreed to recommend the addition of screening for Critical Cyanotic Congenital Heart Disease to the core panel for universal screening of all newborns in the United States.

22 Sep 2010

Phase I/II DIGNITY trial abstract of ThermoDox accepted for poster session at 2010 Breast Cancer Symposium

Celsion Corporation announced today that an abstract on its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 2010 Breast Cancer Symposium. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.

22 Sep 2010

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

An eminent international panel of judges has selected Eli Lilly and Company to receive a World Business and Development Award for demonstrating what can be achieved through successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB).

22 Sep 2010

Smoking during pregnancy adversely affects children's coordination and physical control

Women who smoke during pregnancy run the risk of adversely affecting their children's coordination and physical control according to a new study from örebro University, Sweden, published in the Journal of Epidemiology and Community Health.

22 Sep 2010

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

St. Jude Medical, Inc., a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device Registry. The results reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures.

22 Sep 2010

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).

22 Sep 2010

Health reform's six month implementation marked with new provisions

The Contra Costa Times: "Six months after passage of the federal health reform law, major provisions will kick in that supporters say will make it easier for Americans to get and keep health insurance. … Among the major changes: Insurance companies will no longer be able to cancel policies because someone becomes sick, set lifetime caps on coverage or deny insurance to children with pre-existing conditions. … In addition to enabling young people to remain on their parents' policies up to age 26, several other major provisions kick in on Thursday.

22 Sep 2010

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.

22 Sep 2010

Protein zyxin necessary for maintenance and repair of cell's cytoskeleton

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.

22 Sep 2010

ART closes new $8.5 million venture financing round

Arterial Remodeling Technologies ("ART") announced today that it has closed on a new venture financing round of $8.5 million from existing investors Matignon Technologies and Amundi Private Equity Funds, along with new investor InnoBio Fund managed by CDC Entreprises. Total investment in the Company is now $17 million.

22 Sep 2010

Medical News

Communication breakdown exists between people with chronic pain, health care providers: Survey

Results of custirsen Phase 2 trial for advanced prostate cancer published in Journal of Clinical Oncology

MHPA statement highlights common ground between Medicaid health plans, PCMH model

ImThera Medical releases interim results of clinical study on neurostimulation device for treating OSA

Forensic DNA World Map Project launched

George Higginson Professor to receive 2010 Warren Alpert Foundation Prize

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

Study finds no benefit from self-management counseling in patients with heart failure

Feeding Your Kids challenges families to take 42-day program to combat childhood obesity

Newborn Coalition praises SACHDNC's Critical Congenital Heart Disease universal screening recommendation

Phase I/II DIGNITY trial abstract of ThermoDox accepted for poster session at 2010 Breast Cancer Symposium

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

Smoking during pregnancy adversely affects children's coordination and physical control

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Health reform's six month implementation marked with new provisions

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

Protein zyxin necessary for maintenance and repair of cell's cytoskeleton

ART closes new $8.5 million venture financing round

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News